SPYRE THERAPEUTICS, INC. Voting Outcome
Historical shareholder voting results from retained filings, including every disclosed proposal and director nominee. Vote counts are as filed, not split-adjusted, and displayed in K/M/B/T. — means the category was not reported or no vote was held. Frequency votes preserve each choice. All retained years remain available through pagination.
| Meeting / report date | Proposal / nominee | Outcome | For (shares) | Against (shares) | Abstain (shares) | Withheld (shares) | Broker non-votes (shares) | Filed | Frequency choices (shares) | Document |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |